The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of fexagratinib (Fexa) in Chinese patients (pts) with metastatic or unresectable urothelial carcinoma (mUC) harboring FGF receptor (FGFR) genetic alterations.
 
Xiaojie Bian
No Relationships to Disclose
 
Shanshan Wang
No Relationships to Disclose
 
Dingwei Ye
No Relationships to Disclose
 
Shaoxing Zhu
No Relationships to Disclose
 
Xin Gou
No Relationships to Disclose
 
Benkang Shi
No Relationships to Disclose
 
Jun Xiao
No Relationships to Disclose
 
Bin Hu
No Relationships to Disclose
 
Xianling Liu
No Relationships to Disclose
 
Shusuan Jiang
No Relationships to Disclose
 
Haitao Liu
No Relationships to Disclose
 
Chaohong He
No Relationships to Disclose
 
Xiaoping Zhang
No Relationships to Disclose
 
Zhiwen Chen
No Relationships to Disclose
 
Xinli Kang
No Relationships to Disclose
 
Changfu Li
No Relationships to Disclose
 
Ning Xu
No Relationships to Disclose
 
Yong Yang
No Relationships to Disclose
 
Kun Li
No Relationships to Disclose
 
Qilin Wang
No Relationships to Disclose